He’s taken potshots into the tech industry through a kind of “crypto-based drug discovery platform,” and he’s been making a scene telling criminally charged crypto bros that “jail’s not so bad.”But his attempt to regain the attention of the drug industry may bite him in the posterior, as a federal agency wants the courts to take him to task for violating an order he never, ever work in the pharmaceutical industry again.On Friday, the Federal Trade Commission asked a federal judge to hold Shkreli in contempt of court, saying the Pharma Bro wasn’t giving the agency the information it required to determine if he’s trying to break back into the pharmaceutical industry.FTC competition bureau chief Holly Vedova said the agency is ready to “deploy the full scope of its authorities to enable a comprehensive investigation.”Though both state and federal entities have sued the ex-CEO, Shkreli was never charged for his scheme to hike up prices of the life-saving drug Daraprim.The agency mentioned that the former pharma exec promised he would send over documents via email complaining there were “too many.”New York-based attorney Brianne Murphy is listed in the FTC complaint as Shkreli’s most recent counsel.In a phone interview, Murphy told us that though she doesn’t represent Shkreli in the matter of the FTC order, they plan to “resolve the misunderstanding quickly” by supplying the supplemental information requested."